Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
74.4M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
17.4M
-
Shares change
-
-128K
-
Total reported value, excl. options
-
$180M
-
Value change
-
-$3.16M
-
Number of buys
-
27
-
Number of sells
-
-21
-
Price
-
$10.36
Significant Holders of Corvus Pharmaceuticals, Inc. - Common Stock (CRVS) as of Q4 2017
61 filings reported holding CRVS - Corvus Pharmaceuticals, Inc. - Common Stock as of Q4 2017.
Corvus Pharmaceuticals, Inc. - Common Stock (CRVS) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.4M shares
of 74.4M outstanding shares and own 23.42% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (5.38M shares), Novo Holdings A/S (3.24M shares), ADAMS STREET PARTNERS LLC (2.69M shares), FMR LLC (1.28M shares), BlackRock Inc. (670K shares), EcoR1 Capital, LLC (588K shares), JENNISON ASSOCIATES LLC (467K shares), BVF INC/IL (459K shares), Rock Springs Capital Management LP (423K shares), and Vanguard Group Inc (386K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.